AMA Designation Statement
Project ECHO® designates this live activity for a maximum of 21 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Project ECHO®, in compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, requires that anyone who is in a position to control the content of an educational activity disclose all relevant financial relationships they have had within the last 24 months with an ineligible company.
None of the planners and presenters for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Dr. Alan Hakim, Prof. Lara Bloom, Stacey Simmonds, Sacha Aziz, Dr. Adrijana Kekic, Dr. Alan Pocinki, Dr. Chad Shepherd, Dr. Chip Norris, Dr. Christina Laukaitis, Constance O’Connor, Dr. Dacre Knight, Dr.Ellen Elias, Emily Block, Emily Rich, Dr. Heidi Collins, Dr. Irman Forghani, Dr. Isabelle Brock, Jacqui Main, Dr. Jane Simmonds, Jeannie Di Bon, Jennifer Glayzer, Dr. Jessica Salyers, Dr. John Heusinkveld, Dr. Jordan Tishler, Dr. Keren Machol, Laurie Bilyeu, Dr. Leslie Russek, Dr. Mark Lavallee, Prof. Martin Birchall, Maureen Kelly Galindo, Dr. Melissa Russo, Dr. Natalie Blagowidow, Natasha Silverman, Dr. Nimish Mittal, Dr. Paldeep Atwal, Patricia Stott, Dr. Patrick Agnew, Dr. Rebecca Schaffer, Dr. Sally Pezaro, Dr. Sarah Schwartz, Scarlett Eagle, Dr. Serwet Demirdas, Dr. Shar Hashemi, Sophie Roberts, Dr. Sumana Koduri, Dr. William Ericson, Emma-Louise Williams, Susan Hawkins.
The following planners/presenters listed below have disclosed that they have a relevant financial relationship with an ineligible company.
|Nature of Relationship||Name of Ineligible Company|
|Dr. Anne Maitland||Speaker||Blueprint Medicines|
|Dr. Clair Francomano||Consultant||Acer Therapeutics|
|Dr. Hal Dietz||Advisor, Individual Stocks and Stock Options, Nonexecutive Director Ownership Interest||Aytu BioPharma, GlaxoSmithKline|
|Kevin Muldowney||Ownership Interest||Muldowney Publishing|
|Kathleen Muldowney||Ownership Interest, Royalties, or Patent Beneficiary||Muldowney Publishing|
|Dr. Laura Pace||Advisor||Mauna Kea|
|Dr. Gisela Chelimsky||Ownership Interest||PainStakers, LLC|
|Dr. David Saperstein||Advisor, Speaker||CSL-Behring, Argenyx, Grifols |
|Dr. James Kustow||Consultant, Speaker||Flynn Pharma|
|Dr. Fraser Henderson||Consultant||LIFE SPINE Inc.|
All of the relevant financial relationships listed for these individuals have been mitigated.